University of Arizona Researchers Embark on Asthma-Related Precision Medicine Initiative | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

University of Arizona Researchers Embark on Asthma-Related Precision Medicine Initiative

January 24, 2018
by Rajiv Leventhal
| Reprints

University of Arizona researchers are launching an international consortium with the goal to stop asthma in childhood and continue work toward an overall cure for the disease.

The researchers will specifically set out to determine if better regulation of a protein found in lung cells might impact persistence of asthma from childhood to adulthood, working toward personalized therapies for people with adult chronic asthma.

Stefano Guerra, M.D., Ph.D., a professor in the University of Arizona Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, recently received a $3.6 million, five-year grant from the National Institute of Allergy and Infectious Diseases to study the protein CC16, a biomarker of injury to epithelial cells that line the lungs and are believed to be a protective mediator in the airway inflammatory process. The protein is produced mainly by “club cells,” also known as “bronchiolar exocrine cells,” in the outer airways of the lungs, but can be measured in blood circulation, as the researchers explained in an announcement.

“The project establishes an international consortium among some of the world’s leading asthma research groups that provide unique data on thousands of participants followed from birth well into their adult life,” Dr. Guerra said in a press release.

These groups include the Tucson Children’s Respiratory Study, launched in 1980 by the Arizona Respiratory Center (now the UA Health Sciences Asthma and Airway Disease Research Center), Sweden’s BAMSE (the Swedish abbreviation for Children, Allergy, Milieu, Stockholm, Epidemiology) and the United Kingdom’s Manchester Asthma and Allergy Study (MAAS). Each involve longitudinal research with observation of patients over decades.

"This study builds upon the already outstanding work on asthma-related research at the University of Arizona to move forward on treatments for a disease that is affecting the quality of so many lives, especially our children," said UA President Robert C. Robbins. "Personalized medicine is the future of healthcare, and the UA is recognized as a leader in this emerging and vitally important area. I am excited to learn what Dr. Guerra and his colleagues find."

Guerra noted that ultimately, the team’s objective is to establish the value of CC16 as a protective factor from persistence of asthma (into adulthood) and evaluate its possible use in identifying which patients are at high risk and novel therapeutic interventions to help them.

If these studies help determine CC16 deficits’ role in persistent asthma, the next step would be to evaluate CC16 augmentation as a therapeutic intervention in this disease, by either administering the human recombinant CC16 protein (which already is being tested in airway diseases) or molecules that increase a body’s internal production of CC16, according to the researchers.

2018 Denver Health IT Summit

Renowned leaders in U.S. and North American healthcare gather throughout the year to present important information and share insights at the Healthcare Informatics Health IT Summits.

July 12 - 13, 2018 | Denver

Topics

News

Boston Children's Accelerates Data-Driven Approach to Clinical Research

In an effort to bring a more data-driven approach to clinical research, Boston Children’s Hospital has joined the TriNetX global health research network.

Paper Records, Films Most Common Type of Healthcare Data Breach, Study Finds

Despite the high level of hospital adoption of electronic health records and federal incentives to do so, paper and films were the most frequent location of breached data in hospitals, according to a recent study.

AHA Appoints Senior Advisor for Cybersecurity and Risk

The American Hospital Association (AHA) has announced that John Riggi has joined the association as senior advisor for cybersecurity and risk.

Report: Healthcare Accounted for 45% of All Ransomware Attacks in 2017

Healthcare fell victim to more ransomware attacks than any other industry in 2017, according to a new report from global cybersecurity insurance company Beazley.

Study: Use of EHRs Does Not Reduce Administrative Costs

A recent study by Duke University and Harvard Business School researchers found that costs for processing a single bill ranged from $20 for a primary care visit to $215 for an inpatient surgical procedure, or up to 25 percent of revenue.

Kibbe to Step Down as CEO of DirectTrust

David Kibbe, M.D., M.B.A., announced he would step down as president and CEO of DirectTrust at the end of the year.